You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ladakamycin

Showing 26 - 50 of 90
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia With Multilineage Dysplasia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Blasts 20-30 Percent of

Active, not recruiting
  • Acute Myeloid Leukemia With Multilineage Dysplasia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells Trial in

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
May 16, 2022

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2021

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia Trial in Los Angeles, Sacramento, Oklahoma City (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Los Angeles, California
  • +2 more
Mar 11, 2022

Acute Myeloid Leukemia Trial in Houston (Azacitidine, Cladribine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2022

Acute Myeloid Leukemia, Blasts 20-30 Percent of Bone Marrow Nucleated Cells, Chronic Myelomonocytic Leukemia Trial in Baltimore,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Baltimore, Maryland
  • +2 more
Feb 25, 2022

Acute Myelogenous Leukemia Trial in Rochester, Milwaukee (Azacitidine, Venetoclax, Pevonedistat)

Active, not recruiting
  • Acute Myelogenous Leukemia
  • Rochester, Minnesota
  • +1 more
Sep 21, 2021

Acute Myeloid Leukemia Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspirate)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Nov 4, 2022

Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL, Leukemia Cutis, Recurrent Acute Myeloid Leukemia Trial in New York

Completed
Has Results
  • Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 11, 2021

Acute Bilineal Leukemia, Acute Biphenotypic Leukemia, Acute Myeloid Leukemia Trial in Houston (Azacitidine, Venetoclax)

Recruiting
  • Acute Bilineal Leukemia
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2021

FLT3 Gene Mutation Negative, FLT3 Internal Tandem Duplication Positive, Recurrent Acute Myeloid Leukemia Trial in Houston

Active, not recruiting
  • FLT3 Gene Mutation Negative
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 16, 2022

Peripheral T-cell Lymphoma Trial in Beijing (Sintilimab, Chidamide, Azacidine)

Not yet recruiting
  • Peripheral T-cell Lymphoma
  • Beijing, Beijing, China
    Beijing
Mar 5, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspiration)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • (no location specified)
Jan 13, 2023

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia Arising

Not yet recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • (no location specified)
Nov 8, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Tumor, Acute Myeloid

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • (no location specified)
Nov 15, 2022

Stem Cell Transplantation, Leukemia Trial in Houston (Fludarabine, Busulfan, Thymoglobulin)

Completed
Has Results
  • Stem Cell Transplantation
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 21, 2021

Acute Myeloid Leukemia, Hematopoietic and Lymphoid System Tumor, Myelodysplastic Syndrome Trial in United States (Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2021

Leukemia, Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome Trial in Houston (drug, biological, other)

Recruiting
  • Leukemia
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 13, 2021

Leukemia Trial in Houston (Decitabine, Azacitidine)

Completed
Has Results
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 1, 2020

Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, Fibroblast Growth Factor Basic Form Measurement, FLT3 Internal

Recruiting
  • Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
  • +4 more
  • Chicago, Illinois
    Northwestern University
Apr 30, 2021

Colorectal Cancer Trial in Houston (Azacitidine, Capecitabine, Oxaliplatin)

Completed
Has Results
  • Colorectal Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 3, 2020

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Saint Louis (drug, radiation, procedure)

Terminated
  • Acute Myeloid Leukemia
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Oct 16, 2020

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute

Terminated
Has Results
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 29, 2020

Leukemia Trial in Houston (Azacitidine (AZA), Tyrosine kinase inhibitor (TKI), Azacitidine)

Completed
  • Leukemia
  • Azacitidine (AZA)
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 3, 2020

Refractory Multiple Myeloma Trial in Cleveland (azacitidine, lenalidomide, dexamethasone)

Completed
Has Results
  • Refractory Multiple Myeloma
  • Cleveland, Ohio
  • +1 more
Oct 20, 2020